Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
26/08/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Presentation of Interim Results from Phase 3b/4 ANNEXA™-4 Study of AndexXa™ (andexanet ...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/08/201623h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
19/08/201614h30GlobeNewswire Inc.Portola Pharmaceuticals Announces Validation of Marketing Authorization Application (MAA) by European Medicines Agency (EMA) ...NASDAQ:PTLAPortola Pharmaceuticals Inc
18/08/201604h57GlobeNewswire Inc.Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXa™ (andexane...NASDAQ:PTLAPortola Pharmaceuticals Inc
09/08/201622h42Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
09/08/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
02/08/201622h05GlobeNewswire Inc.Portola Pharmaceuticals to Announce Second Quarter 2016 Financial Results and Host Conference Call on Tuesday, August 9NASDAQ:PTLAPortola Pharmaceuticals Inc
22/06/201614h20PR Newswire (US)Biotechnology Stocks in Motion -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera PharmaNASDAQ:PTLAPortola Pharmaceuticals Inc
21/06/201623h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
14/06/201612h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
01/06/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Dosing of First Patient in Phase 2a Study of Cerdulatinib for Treatment of Hematologic Canc...NASDAQ:PTLAPortola Pharmaceuticals Inc
31/05/201622h05GlobeNewswire Inc.Portola Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
27/05/201614h45GlobeNewswire Inc.Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thro...NASDAQ:PTLAPortola Pharmaceuticals Inc
24/05/201618h23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PTLAPortola Pharmaceuticals Inc
23/05/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and AndexXa™ (andexanet alfa) at International ...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/05/201614h35PR Newswire (US)How are Investors Treating These Biotech? - Portola Pharma, Vitae Pharma, Anthera Pharma, and Intra-Cellular TherapiesNASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
29/04/201622h40Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
28/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5NASDAQ:PTLAPortola Pharmaceuticals Inc
14/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Cerdulatinib Data Presentation at American Association for Cancer Research (AACR) ...NASDAQ:PTLAPortola Pharmaceuticals Inc
11/04/201617h57Edgar (US Regulatory)Schedule 13gNASDAQ:PTLAPortola Pharmaceuticals Inc
06/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Presentation of Phase 3 APEX Study Results at International Society on Thrombosis and Haemo...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement with Daiichi Sankyo to Develop Andexanet Alfa with Edoxa...NASDAQ:PTLAPortola Pharmaceuticals Inc
30/03/201617h50Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTLAPortola Pharmaceuticals Inc
24/03/201614h44Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNASDAQ:PTLAPortola Pharmaceuticals Inc
24/03/201614h40Dow Jones NewsPortola's Shares Plunge on Blood Clot TrialNASDAQ:PTLAPortola Pharmaceuticals Inc
24/03/201612h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Topline Results from Phase 3 APEX Trial of Betrixaban for Prevention of Blood Clots in Acut...NASDAQ:PTLAPortola Pharmaceuticals Inc
24/03/201609h00GlobeNewswire Inc.Portola Pharmaceuticals to Hold Conference Call on Thursday, March 24, at 8:30 am ETNASDAQ:PTLAPortola Pharmaceuticals Inc
10/03/201601h46GlobeNewswire Inc.Portola Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
10/03/201601h46GlobeNewswire Inc.Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2015 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA